Resalis Therapeutics
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
){kind=logo}
)